Masahiko Tameda

1.7k total citations · 1 hit paper
30 papers, 1.3k citations indexed

About

Masahiko Tameda is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Masahiko Tameda has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Hepatology and 11 papers in Epidemiology. Recurrent topics in Masahiko Tameda's work include Liver Disease Diagnosis and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Masahiko Tameda is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Masahiko Tameda collaborates with scholars based in Japan, United States and Switzerland. Masahiko Tameda's co-authors include Yoshiyuki Takei, Kazushi Sugimoto, Katsuya Shiraki, Masaaki Ito, Chika Kasai, Junichiro Tanaka, Hidekazu Inoue, Isao Moritani, Yumi Oya and Kojiro Takase and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Scientific Reports.

In The Last Decade

Masahiko Tameda

29 papers receiving 1.2k citations

Hit Papers

Comparison of the gut microbiota composition between obes... 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing
    2015 448 citations Chika Kasai, Kazushi Sugimoto et al. BMC Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiko Tameda Japan 17 752 305 263 211 176 30 1.3k
Ali Mencin United States 10 641 0.9× 687 2.3× 169 0.6× 317 1.5× 131 0.7× 22 1.4k
Debora Compare Italy 24 881 1.2× 436 1.4× 313 1.2× 100 0.5× 120 0.7× 57 2.0k
Ningwen Tai United States 21 608 0.8× 185 0.6× 151 0.6× 88 0.4× 51 0.3× 29 1.3k
Yawen Wang China 19 349 0.5× 355 1.2× 127 0.5× 98 0.5× 96 0.5× 79 1.2k
Shaoyan Xu China 15 1.1k 1.4× 372 1.2× 223 0.8× 83 0.4× 130 0.7× 39 1.7k
Shengdi Wu China 17 354 0.5× 390 1.3× 77 0.3× 282 1.3× 92 0.5× 44 1.1k
Lorenzo Polimeno Italy 25 552 0.7× 407 1.3× 177 0.7× 554 2.6× 74 0.4× 55 1.8k
Leiqi Xu China 14 957 1.3× 171 0.6× 238 0.9× 44 0.2× 122 0.7× 22 1.5k

Countries citing papers authored by Masahiko Tameda

Since Specialization
Citations

This map shows the geographic impact of Masahiko Tameda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Tameda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Tameda more than expected).

Fields of papers citing papers by Masahiko Tameda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiko Tameda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Tameda. The network helps show where Masahiko Tameda may publish in the future.

Co-authorship network of co-authors of Masahiko Tameda

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiko Tameda. A scholar is included among the top collaborators of Masahiko Tameda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiko Tameda. Masahiko Tameda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamada, Yasuhiko, Masahiko Tameda, & Hayato Nakagawa. (2025). Metachronous Liver Metastasis during Long-term Follow-up after Endoscopic Submucosal Dissection of a Small Rectal Neuroendocrine Neoplasm. Internal Medicine. 64(15). 2323–2327.
2.
Sugimoto, Kazushi, et al.. (2023). A case of steatohepatitis that developed after pancreaticoduodenectomy and progressed rapidly to liver cirrhosis and hepatocellular carcinoma. Clinical Journal of Gastroenterology. 16(5). 715–719. 1 indexed citations
3.
Povero, Davide, Masahiko Tameda, Akiko Eguchi, et al.. (2022). Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis. Scientific Reports. 12(1). 3027–3027. 18 indexed citations
4.
Calvente, Carolina Jiménez, et al.. (2019). MicroRNA 223 3p Negatively Regulates the NLRP3 Inflammasome in Acute and Chronic Liver Injury. Molecular Therapy. 28(2). 653–663. 85 indexed citations
5.
Eguchi, Akiko, Yukinori Koyama, Alexander Wree, et al.. (2018). Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligation. Journal of Molecular Medicine. 96(6). 575–583. 21 indexed citations
6.
Kasai, Chika, Kazushi Sugimoto, Isao Moritani, et al.. (2016). Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. BMC Gastroenterology. 16(1). 119–119. 16 indexed citations
7.
Kasai, Chika, Kazushi Sugimoto, Isao Moritani, et al.. (2015). Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterology. 15(1). 100–100. 448 indexed citations breakdown →
8.
9.
Tameda, Masahiko, Kazushi Sugimoto, Katsuya Shiraki, et al.. (2015). Substitution in Amino Acid 70 of Hepatitis C Virus Core Protein Changes the Adipokine Profile via Toll-Like Receptor 2/4 Signaling. PLoS ONE. 10(6). e0131346–e0131346. 14 indexed citations
10.
Inagaki, Yuji, Katsuya Shiraki, Kazushi Sugimoto, et al.. (2015). Epigenetic regulation of proliferation and invasion in hepatocellular carcinoma cells by CBP/p300 histone acetyltransferase activity. International Journal of Oncology. 48(2). 533–540. 35 indexed citations
11.
Sugimoto, Kazushi, Katsuya Shiraki, Masahiko Tameda, et al.. (2014). Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression. International Journal of Oncology. 45(3). 1059–1064. 25 indexed citations
12.
Tameda, Masahiko, Kazushi Sugimoto, Katsuya Shiraki, et al.. (2014). Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility. International Journal of Oncology. 45(2). 541–548. 35 indexed citations
13.
Inagaki, Yuji, Kazushi Sugimoto, Katsuya Shiraki, et al.. (2013). The long-term effects of splenectomy and subsequent interferon therapy in patients with HCV-related liver cirrhosis. Molecular Medicine Reports. 9(2). 487–492. 12 indexed citations
14.
Tameda, Masahiko, Katsuya Shiraki, Kazushi Sugimoto, et al.. (2013). Des‐γ‐carboxy prothrombin ratio measured by P‐11 and P‐16 antibodies is a novel biomarker for hepatocellular carcinoma. Cancer Science. 104(6). 725–731. 24 indexed citations
15.
Sugimoto, Kazushi, Katsuya Shiraki, Masahiko Tameda, et al.. (2013). The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma. Oncology Reports. 29(5). 1737–1743. 24 indexed citations
16.
Sugimoto, Kazushi, Katsuya Shiraki, Masahiko Tameda, et al.. (2012). Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma. International Journal of Oncology. 42(1). 101–108. 16 indexed citations
17.
Inoue, H., et al.. (2012). Hemosuccus pancreaticus caused by in situ carcinoma of the pancreas. Endoscopy. 44(S 02). E336–E337. 6 indexed citations
18.
Sugimoto, Kazushi, Katsuya Shiraki, Junichiro Tanaka, et al.. (2010). Development of hepatocellular carcinoma in patients with chronic hepatitis C more than 10 years after sustained virological response to interferon therapy. Oncology Letters. 1(3). 427–430. 13 indexed citations
19.
Suzuki, Masahiro, Kazushi Sugimoto, Junichiro Tanaka, et al.. (2010). Up-regulation of glypican-3 in human hepatocellular carcinoma.. PubMed. 30(12). 5055–61. 41 indexed citations
20.
Tameda, Masahiko. (2005). Aspartate aminotransferase-immunoglobulin complexes in patients with chronic liver disease. World Journal of Gastroenterology. 11(10). 1529–1529. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Mencin Breakdown of academic impact, for papers by Debora Compare Breakdown of academic impact, for papers by Ningwen Tai Breakdown of academic impact, for papers by Yawen Wang Breakdown of academic impact, for papers by Shaoyan Xu Breakdown of academic impact, for papers by Shengdi Wu Breakdown of academic impact, for papers by Lorenzo Polimeno Breakdown of academic impact, for papers by Leiqi Xu
Rankless by CCL
2026